| Trial ID: | L5462 |
| Source ID: | NCT00862875
|
| Associated Drug: |
Detemir Or Glargine
|
| Title: |
Levemir-Body Composition and Energy Metabolism
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Detemir or Glargine
|
| Outcome Measures: |
Primary: Changes in total fat mass (in kg), Baseline and 6 months | Secondary: Epicardial fat, trunk fat, total fat free mass, weight & waist circumference, HbA1c, fasting glucose, RMR, TEF,PAEE & TEE, energy intake., Baseline and 6 months
|
| Sponsor/Collaborators: |
Sponsor: Institut de Recherches Cliniques de Montreal | Collaborators: Novo Nordisk A/S|McMaster University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
42
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-03
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2014-05-07
|
| Locations: |
Institut de Recherches Cliniques de Montréal, Montréal, Quebec, H2W 1R7, Canada
|
| URL: |
https://clinicaltrials.gov/show/NCT00862875
|
